2020
DOI: 10.1371/journal.pone.0232050
|View full text |Cite
|
Sign up to set email alerts
|

Performance of a multiplexed amplicon-based next-generation sequencing assay for HLA typing

Abstract: Background Next-generation sequencing (NGS) has enabled efficient high-resolution typing of human leukocyte antigen (HLA) genes with minimal ambiguity. Most commercially available assays amplify individual or subgroup of HLA genes by long-range PCR followed by library preparation and sequencing. The AllType assay simplifies the workflow by amplifying 11 transplantrelevant HLA genes in one PCR reaction. Here, we report the performance of this unique workflow evaluated using 218 genetically diverse samples. Meth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 35 publications
0
10
0
Order By: Relevance
“…Genomic DNA was extracted from remnant peripheral blood specimens using the EZ1 DNA Blood 350 μl Kit (Qiagen, Hilden, Germany). A total of 192 samples were typed by the AllType assay (One Lambda, West Hills, CA) on the Ion Chef/S5 Ion Torrent platform 25 . A total of 42 samples were amplifed using the NGS LR kit (One Lambda, West Hills, CA) and sequenced following the SQK‐LSK109 protocol on the R10.3 MinION flow cells (FLO‐MIN111, Oxford Nanopore Technologies) 26 .…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Genomic DNA was extracted from remnant peripheral blood specimens using the EZ1 DNA Blood 350 μl Kit (Qiagen, Hilden, Germany). A total of 192 samples were typed by the AllType assay (One Lambda, West Hills, CA) on the Ion Chef/S5 Ion Torrent platform 25 . A total of 42 samples were amplifed using the NGS LR kit (One Lambda, West Hills, CA) and sequenced following the SQK‐LSK109 protocol on the R10.3 MinION flow cells (FLO‐MIN111, Oxford Nanopore Technologies) 26 .…”
Section: Methodsmentioning
confidence: 99%
“…A total of 192 samples were typed by the AllType assay (One Lambda, West Hills, CA) on the Ion Chef/S5 Ion Torrent platform. 25 A total of 42 samples were amplifed using the NGS LR kit (One Lambda, West Hills, CA) and sequenced following the SQK-LSK109 protocol on the R10.3 MinION flow cells (FLO-MIN111, Oxford Nanopore Technologies). 26 Genotypes of HLA-A, -B, -C, -DPA1, -DPB1, -DQA1, -DQB1, -DRB1, -DRB3/4/5 genes were assigned based on keyexon sequences (G groups) and limited to the 2-field resolution.…”
Section: Hla Typing Of Casesmentioning
confidence: 99%
“…Genomic DNA was extracted from a whole blood specimen. HLA typing was performed using the AllType assay (One Lambda, West Hills, CA) with the Ion Torrent S5 sequencing platform, which has been validated as a lab‐developed test 3 . Data analysis and allele assignment were performed using the TypeStream Visual software (version 2.0) and the IPD‐IMGT/HLA Database version 3.40.0 4 .…”
Section: Figurementioning
confidence: 99%
“…HLA typing was performed using the AllType assay (One Lambda, West Hills, CA) with the Ion Torrent S5 sequencing platform, which has been validated as a lab-developed test. 3 Data analysis and allele assignment were performed using the TypeStream Visual software (version 2.0) and the IPD-IMGT/HLA Database version 3.40.0. 4 The software identified HLA-B*07:02 as the closest allele to the novel allele, and the result was flagged due to a mismatch, or variant base, in exon 3.…”
mentioning
confidence: 99%
“…The high throughput of NGS also allows multiplexed sequencing of DNA enriched from multiple genes and many samples in one run, which maximizes the efficiency and lowers the cost per sample. [11][12][13][14][15][16] In this report we describe the characterization of a novel null HLA-DQB1 allele, detected by PCR-SBT but not by NGS, and identified during the routine typing of a family group, looking for a fully matched hematopoietic stem cell donor for an Italian patient with acute myeloid leukemia. The new allele was first detected in the patient's peripheral blood sample and in order to exclude Francesco Ingrassia and Alice Pecoraro contributed equally to this study.…”
Section: Introductionmentioning
confidence: 99%